{"prompt": "['Trial ID: LP0133-1273', 'Date: 07-Dec-2018', 'Version: 3.0', 'Page 109 of 128', 'Possibly', 'Follows a reasonable temporal sequence from the administration of the', 'related', 'IMP.', \"Could also be reasonably explained by the subject's clinical state,\", 'environmental or toxic factors or other therapies administered to the', 'subject.', 'Follows a known pattern of response to the IMP.', 'Not related', 'Does not follow a reasonable temporal sequence from administration of the', 'IMP.', \"Is better explained by other factors like the subject's clinical state,\", 'environmental or toxic factors or other therapies administered to the', 'subject.', 'Does not reappear or worsen upon re-challenge.', 'Does not follow a known pattern of response to the IMP.', 'Outcome', \"The outcome of the event according to the investigator's clinical judgement should be\", 'classified using the categories below.']['Trial ID: LP0133-1273', 'Date: 07-Dec-2018', 'Version: 3.0', 'Page 110 of 128', 'Recovered/', 'The event has stopped. The stop date of the event must be recorded.', 'resolved', 'Recovering/', 'The subject is clearly recovering from an event. The event is not yet', 'resolving', 'completely resolved.', 'Not', 'Event is still ongoing.', 'recovered/', 'not resolved', 'Recovered/', 'The event has reached a state where no further changes are expected, and the', 'resolved with', 'residual symptoms are assumed to persist. An example is hemiparesis after', 'sequelae', 'stroke.', 'The stop date of the event must be recorded. In case of a SAE, the sequelae', 'should be specified.', 'Fatal', 'The subject has died as a consequence of the event. Date of death is recorded', 'as stop date for the AE.', 'Unknown', 'Unknown to investigator, e.g., subject lost to follow-up.', 'Note that as per the above definition, LEO uses \"RECOVERED/RESOLVED\" only if an', 'event has actually stopped. According to the CDISC definition, the category', '\"RECOVERED/RESOLVED\" also includes events which have improved. However,', 'following the LEO definitions above, such an improved event will instead be classified as', '\"NOT RECOVERED/NOT RESOLVED\" or \"RECOVERING/RESOLVING\".', 'Similarly, it should be noted that as per the above definition, LEO uses', '\"RECOVERED/RESOLVED WITH SEQUELAE\" only if an event has reached a state where', 'the residual symptoms are assumed to persist. According to CDISC, an event is considered', '\"WITH SEQUELAE\", if it has \"retained pathological conditions\". Consequently, it is likely', 'that some of the events classified by LEO with the outcome \"RECOVERED/RESOLVED', 'WITH SEQUELAE\" could have been classified with the outcome', '\"RECOVERED/RESOLVED\" according to the CDISC definition.', 'For SAEs which have stabilised and cannot be expected to resolve during study or safety', 'follow-up periods, for example chronic illnesses, \"not resolved\\' is accepted as the final', 'outcome and a statement that the SAE has stabilised or is chronic should be added to the', 'narrative in the SAE form.']['Trial ID: LP0133-1273', 'Date: 07-Dec-2018', 'Version: 3.0', 'Page 111 of 128', 'Appendix 3: Trial governance considerations', 'Appendix 3A: Regulatory and ethical considerations', 'This trial will be conducted in accordance with the protocol and with the following:', 'Consensus ethical principles derived from international guidelines including the', 'current version of the Declaration of Helsinki (26) and Council for International', 'Organizations of Medical Sciences (CIOMS) International Ethical Guidelines (27).', 'Current version of applicable International Council for Harmonisation (ICH) Good', 'Clinical Practice (GCP) Guidelines (28).', \"EU's General Data Protection Regulation 2016/679 of 27 April 2016.\", 'Applicable laws and regulations.', 'The appropriate regulatory authorities must be notified of/approve the clinical trial as', 'required.', 'Any documents that the IRB/IEC may need to fulfil its responsibilities (such as the trial', \"protocol, protocol amendments, Investigator's Brochure, subject information leaflet, informed\", 'consent forms, or advertisements) will be submitted to the IRB/IEC. These documents must', 'be reviewed and approved by the IRB/IEC before the trial is initiated.', 'Any amendments to the protocol must be approved by/receive favourable opinion from', 'relevant regulatory authorities and IRBs/IECs, as required, prior to implementation.', 'The principal investigator will be responsible for the following, if required by local', 'legislation:', 'Providing written summaries of the status of the trial to the IRB/IEC annually or more', 'frequently in accordance with the requirements, policies, and procedures established', 'by the IRB/IEC.', 'Notifying the local IRB/IEC of SAEs or other significant safety findings as required', 'by IRB/IEC procedures.', 'Providing oversight of the conduct of the trial at the trial site and adherence to', 'applicable national and international legislation.']\n\n###\n\n", "completion": "END"}